Clinical Trials Listings

Clinical Trials

ProstateA Phase 1/2 Study of REGN5678 (Anti-PSMAxCD28) With Cemiplimab (Anti-PD-1) in Patients With Metastatic Castration-resistant Prostate CancerPrincipal Investigator: Joseph Kim
Lip, Oral Cavity and PharynxA Pilot Study of CUE-101 in Combination With Pembrolizumab in Subjects With Newly Diagnosed, Locally Advanced HPV-16 Associated Head and Neck Cancer
ProstateA Study of GSK5458514 Administered Alone or In Combination With Other Anti-Cancer Agents in Participants With Prostate Cancer
Colon, Lung, Other Digestive Organ, Pancreas, Phase IPhase 1/2 Trial of S241656 in Selected RAS/MAPK Mutation- Positive Malignancies
Lymphoid LeukemiaA Phase 2 Study of Blinatumomab in Combination With Chemotherapy for Infants With Newly Diagnosed Acute Lymphoblastic Leukemia With Randomization of KMT2A-Rearranged Patients to Addition of Venetoclax